I have bought more.

74,60€ , 11 pieces

Now my new buy-in is €79.90.

Previously my buy-in was €83.57

Now it can go up again for all I care.

According to ChatGPT:

Novo Nordisk's patents for its drugs and technologies vary by product and region. A significant example is semaglutide, the active ingredient in drugs such as Ozempic and Wegovy. In China, the patent for semaglutide expires in 2026, allowing the introduction of generics in this market. In Europe and Japan, however, patent protection will remain in place until 2031, and in the USA until 2032.

For other Novo Nordisk medicines, such as Xultophy, Tresiba and Ryzodeg, patent protection in Europe runs until 2028 and 2029 respectively, while patent protection for many of the company's other products does not expire until after 2031.

It is important to note that the exact patent terms may vary depending on the country and specific product. The above dates provide a general overview of Novo Nordisk's most important patents.